Primary Care Physicians in Bahrain Show Knowledge Gaps in MS Management
A recent study highlights significant deficiencies in the understanding of multiple sclerosis diagnosis and treatment among primary care physicians in Bahrain.
Only 7.6% of surveyed physicians are familiar with the McDonald criteria for MS diagnosis.
A significant portion of physicians lacks knowledge about relapse management and treatment options.
The study suggests targeted educational initiatives to improve MS care in primary healthcare settings.
A recent cross-sectional study has revealed that primary care physicians in Bahrain possess a solid understanding of multiple sclerosis (MS) characteristics, yet exhibit critical gaps in diagnosing and managing relapses. Conducted across various health centers, the research aimed to assess the knowledge of 428 physicians, with 211 completing the survey, yielding a response rate of 49.3%.
The findings indicate that while many physicians demonstrated acceptable knowledge regarding MS demographics, causes, and symptoms, significant deficiencies were noted in their understanding of diagnostic criteria and relapse management. For instance, over half of the respondents correctly identified MS as an immune-mediated disorder affecting the central nervous system, and 67.3% recognized its higher prevalence in females. However, only 7.6% were familiar with the McDonald criteria necessary for diagnosing MS.
In terms of relapse management, the study highlighted that while 76.8% of physicians acknowledged that a relapse involves new or worsening neurological symptoms, only 33.7% understood that these symptoms must persist for at least 24 hours. Furthermore, just 41.2% correctly identified the recommended initial treatment of methylprednisolone for MS relapses. These gaps underscore the need for improved education and training in this area.
The study also pointed out that awareness of disease-modifying therapies is lacking, with more than half of the respondents unfamiliar with current treatment options. Among those who were knowledgeable, interferon beta was the most recognized therapy at 64.7%. The researchers noted that higher knowledge scores correlated with attendance at MS-related conferences and greater patient exposure.
To enhance the quality of care, the researchers advocate for targeted educational initiatives focusing on diagnosis, relapse management, and disease-modifying therapies. They also emphasize the importance of collaboration between primary care physicians and MS specialists to streamline care pathways and facilitate earlier, more accurate diagnoses.
